WINT: Rega marang dodolan Windtree Therapeutics

The Windtree Therapeutics (WINT) P/S ratio, as shown on this GURU.Markets chart, allows for a valuation of the business relative to revenue generated from developing drugs for cardiac and pulmonary pathologies, with the value reflecting the current figure. The company's growth relies on synergy with cardiac centers during drug testing. Low geopolitical risks ensure operational stability within Western legal frameworks.

WINT: Kapitalisasi marang pendapatan Windtree Therapeutics 04.07.2022 - 13.11.2026

Rincian analitis perusahaan Windtree Therapeutics (WINT)

- kuotasi saiki lan rata-rata prakiraan nilai:

Rega bursa windtreetx.com|WINT - Prakiraan konsensus analis

- informasi kapitalisasi pasar:

Nilai pasar Windtree|WINT - Rega Nyata Tumbas Perusahaan Kanthi Wutuh

- data nilai buku modal saham:

Nilai Akuntansi Saham Windtree Therapeutics|WINT - Aset Bersih Perusahaan|Multiplikator Kapitalisasi Pasar marang Nilai Buku windtreetx.com|WINT - Total Aset Perusahaan

- rincian struktur utang lan likuiditas bisnis:

Rasio Kabeh Utang marang Dana Pribadi Windtree Therapeutics|WINT - Utang jangka dawa marang modal|Kewajiban jangka cendhak marang modal windtreetx.com|WINT - Utang perusahaan|Rasio utang marang aset resik Windtree|WINT - Utang jangka dawa perusahaan|Utang jangka cendhak perusahaan Windtree Therapeutics|Rasio likuiditas kritis windtreetx.com

- informasi bathi lan kelipatan valuasi:

WINT - Bathi resik|Bathi resik sing dikarepake Windtree Therapeutics|WINT - Koefisien rega marang bathi|Pangali Forward P/E windtreetx.com|WINT - Pangali rega marang bathi tumrap wutah|Koefisien nilai perusahaan marang bathi operasional sadurunge panyusutan Windtree|WINT - Bathi operasional EBITDA|Bathi resik saben saham sajrone patang kuartal pungkasan Windtree Therapeutics|WINT - Bathi resik saben saham (EPS TTM)|Wutah bathi resik saben saham taun-ka-taun sajrone 12 wulan pungkasan windtreetx.com|WINT - Wutah bathi saben saham ing taun lumaku|Prakiraan konsensus wutah bathi saben saham kanggo taun ngarep Windtree Therapeutics

- indikator pendapatan dodolan lan penghasilan bisnis:

WINT - Dodolan perusahaan|Volume dodolan mangsa ngarep perusahaan windtreetx.com|WINT - Multiplikator P/S|Rasio kapitalisasi marang dodolan sing dikarepake Windtree

Analisis fundamental perusahaan:Windtree Therapeutics Inc., WINT

For Windtree Therapeutics (WINT), whose heart failure therapy patents are losing value due to FDA failures, a market value analysis relative to revenue via the revenue multiple reveals a genuine valuation imbalance. The current value of is calculated as the ratio of market capitalization to annual revenue, allowing investors to determine if the company is overvalued amid a chronic shortage of R&D capital.

Perusahaan pesaing

REGN - Rega marang dodolan|Multiplikator P/S IRTC (iRhythm)|Lantheus Holdings (LNTH) - Rega marang dodolan|MLYS: Kapitalisasi marang pendapatan|Rasio kapitalisasi pasar marang pendapatan HTFL (Heartflow Inc)|KMTS (Kestra Medical Technologies) - Kapitalisasi marang pendapatan|ESPR: Kapitalisasi marang volume dodolan|AMRN (Amarin) - Multiplikator P/S|AVR: Rasio kapitalisasi pasar marang pendapatan|Multiplikator P/S TNYA|CVRX - Rega marang dodolan|Rasio rega marang pendapatan Milestone Pharmaceuticals MIST|Rasio kapitalisasi pasar marang pendapatan CRDL|HeartBeam - Multiplikator P/S|TENX - Multiplikator P/S|Adagio Medical Holdings Inc. (ADGM) - Rasio rega marang pendapatan|Rasio rega marang dodolan BCDA (BioCardia Inc)|VTAK (Catheter Precision) - Multiplikator P/S|Rega marang dodolan ARCA Bio ABIO|Kapitalisasi marang pendapatan ACST (Acasti Pharma)|Multiplikator P/S Aerovate Therapeutics Inc. (AVTE)|Verve Therapeutics, Inc. - Kapitalisasi marang pendapatan